The profitability of MBX Biosciences, Inc. over the past 3 years
Chart MBX Biosciences, Inc.: operating income, net income, fiscal 2023–2025 Open the chart →MBX Biosciences, Inc. reported a net loss of $86.97M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $98.06M. It reported a loss in all 3 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$98.06M | -$86.97M |
| 2024ended Dec 31, 2024 | -$68.19M | -$61.92M |
| 2023ended Dec 31, 2023 | -$35.31M | -$32.56M |
Fiscal years as MBX Biosciences, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on MBX Biosciences, Inc.
- The cash flow of MBX Biosciences, Inc.
- The debt of MBX Biosciences, Inc.
- All of MBX Biosciences, Inc.'s financials, charted
Companies of a similar size
- LBTYALiberty Global Ltd.
- GPKGraphic Packaging Holding Co
- BFAMBRIGHT HORIZONS FAMILY SOLUTIONS INC.
- PATKPATRICK INDUSTRIES INC
- DXDYNEX CAPITAL, INC.
Not investment advice. This page shows what MBX Biosciences, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.